GMM PFAUDLER LTD.

GMM Pfaudler Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in effect from September 30, 2026, and will remain open 48 hours after the declaration of the financial results for the quarter ending September 30, 2026 (Q2 FY27). The purpose of this closure is to facilitate the consideration and approval of the Q2 FY27 financial results. The company will separately inform the stock exchanges about the date of the Board Meeting convened for this purpose.

GMM Pfaudler Limited announced the appointment of Mr. Ankit Nayyar as Group Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective November 4, 2026. This follows the resignation of Mr. Alexander Poempner from the same role, with his cessation effective November 4, 2026. Mr. Poempner will continue with the company until December 31, 2026, to ensure a smooth transition. Mr. Nayyar, who joined GMM Pfaudler as Deputy CFO in May 2026, brings nearly two decades of experience in pharmaceuticals, specialty chemicals, manufacturing, and financial services. His prior roles include CFO at PI Health Sciences and leadership positions at Pfizer and Bayer & Monsanto India.

GMM Pfaudler Limited announced a change in its top finance leadership. The Board of Directors accepted the resignation of Mr. Alexander Poempner as Group Chief Financial Officer and Key Managerial Personnel, effective November 4, 2026. Mr. Poempner will continue until December 31, 2026, to facilitate a smooth transition. Concurrently, the Board approved the appointment of Mr. Ankit Nayyar as the new Group CFO and KMP, also effective November 4, 2026. Mr. Nayyar brings nearly two decades of experience in finance across various sectors and joined GMM Pfaudler as Deputy CFO in May 2026.

GMM Pfaudler Limited announced a change in its Group Chief Financial Officer (CFO) and Key Managerial Personnel (KMP). Mr. Alexander Poempner has resigned, effective November 4, 2026, though he will continue to provide transition support until December 31, 2026. The Board has approved the appointment of Mr. Ankit Nayyar as the new Group CFO & KMP, also effective November 4, 2026. Mr. Nayyar brings extensive experience from the pharmaceuticals, specialty chemicals, and manufacturing sectors.

GMM Pfaudler Ltd announced that its wholly owned subsidiary, GMM International S.a.rl., has successfully repaid EUR 7 million towards its outstanding debt facility. This repayment was previously indicated in a press release dated August 5, 2026, for the quarter ended June 30, 2026, and was planned to be funded through internal accruals. The repayment aligns with the company's financial management strategy and strengthens its balance sheet by reducing outstanding debt.

GMM Pfaudler Limited reported its unaudited financial results for Q1 FY27 ended June 30, 2026. Consolidated revenue increased by 16% YoY to ₹925 Crores, while PAT surged 118% YoY to ₹22 Crores. EBITDA saw a 7% YoY decrease but a 25% QoQ increase. Order intake was ₹1,007 Crores, up 16% QoQ, and the backlog stood at ₹2,289 Crores, up 20% YoY. The company highlighted a reorganization into four global divisions to drive growth and efficiencies, and plans to repay approximately EUR 7 million of debt by Q2 FY27. Management expressed optimism about the strategic realignment and improved profitability.

GMM Pfaudler Limited announced its unaudited financial results for Q1 FY27 ended June 30, 2026. Consolidated revenue grew 16% YoY to ₹925 Cr, while PAT surged 118% YoY to ₹22 Cr. EBITDA saw a 7% YoY decline but increased 25% QoQ. The company reported an order intake of ₹1,007 Cr, up 16% QoQ, and a backlog of ₹2,289 Cr, up 20% YoY. Key highlights include a business reorganization into four global divisions, planned debt repayment of EUR 7 million by Q2 FY27, and a shift in dividend payout frequency from semi-annual to annual. Management expressed confidence in the strategic realignment to drive growth and profitability.

GMM Pfaudler Limited announced its unaudited financial results for Q1 FY27 ended June 30, 2026. Consolidated revenue increased by 16% year-on-year to ₹925 Crores, while EBITDA saw a 7% year-on-year decrease to ₹94 Crores. Profit After Tax (PAT) surged by 118% year-on-year to ₹22 Crores, with PAT margin improving to 2.4%. Order intake was ₹1,007 Crores, up 16% QoQ, and the backlog stood at ₹2,289 Crores, up 20% YoY. The company highlighted a reorganization into four global divisions to drive growth and efficiencies, and plans to repay approximately EUR 7 million of debt by Q2 FY27. Management expressed confidence in the strategic realignment and operational initiatives contributing to improved profitability and cash generation.

GMM Pfaudler Ltd has received an ESG Score of 71.1 (Grade B+) for FY26 from SES ESG Research Private Limited, a SEBI registered ESG Rating Provider. This is a marginal decline from the FY25 score of 71.8 (Grade B+). The decrease is primarily attributed to lower scores in environmental parameters. Notably, SES independently prepared this report based on publicly available data for FY26, and the company did not engage SES for this rating. The report is voluntarily issued by SES and is also available on the company's website.

GMM Pfaudler Limited announced its Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026. The Board of Directors approved these results along with the Limited Review Report from the Statutory Auditors. The outcome of the Board Meeting, including the financial results, will be made available on the company's website.